Skip to content
The Nexus
DossierENTITY

Sackler family

Coverage of Sackler family in the Nexus archive.

Earliest in view: Apr 21 · 06:53 UTCMost recent: Apr 23 · 09:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHApr 23 · 09:00 UTCPROPUBLICA
    “A Punch in the Gut”: After Years of Waiting, Many Opioid Victims Will Be Shut Out of Purdue Settlement

    Purdue Pharma's $7.4 billion bankruptcy plan, approved in 2024, excludes tens of thousands of opioid victims who originally filed claims, including Mary Jannotta and her family, whose son died from an overdose. The new settlement slashes payments, imposes stricter eligibility requirements, and removes the option to use sworn affidavits to prove Purdue drug use, impacting victims like those who lost loved ones to overdoses.

  • HEALTHApr 21 · 12:40 UTCTHE GUARDIAN WORLD
    Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case

    Purdue Pharma is set to forfeit $225 million to the US Justice Department as part of a 2020 settlement resolving federal civil and criminal investigations over its role in the opioid crisis. The Sackler family will pay state, local, and tribal governments, individual victims, and others under the agreement.

  • HEALTHApr 21 · 06:53 UTCAP NEWS
    Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow

    Purdue Pharma is set to be sentenced to a $225 million criminal penalty, clearing the way for a $7 billion settlement from the Sackler family to address the opioid crisis. The settlement, approved in 2020, resolves federal and state lawsuits over Purdue's role in aggressively marketing OxyContin, contributing to the opioid epidemic.

Sackler family · Dossier · The Nexus